{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:13Z","timestamp":1740107593248,"version":"3.37.3"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00428-022-03356-x","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T04:03:45Z","timestamp":1655179425000},"page":"327-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The frequency of HER2 amplification and the percentage of membrane staining in HER2 2\u2009+\u2009invasive carcinomas of the breast"],"prefix":"10.1007","volume":"481","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-4050","authenticated-orcid":false,"given":"Andrew H. S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"3356_CR1","doi-asserted-by":"publisher","unstructured":"Pol\u00f3nia A, Canelas C, Caramelo A (2022). The spectrum of HER2 expression in breast cancer: linking immunohistochemistry quantification with in situ hybridization assay. Virchows Arch. (in press). https:\/\/doi.org\/10.1007\/s00428-022-03290-y","DOI":"10.1007\/s00428-022-03290-y"},{"key":"3356_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/jcp.2011.089177","volume":"64","author":"AHS Lee","year":"2011","unstructured":"Lee AHS, Key HP, Bell JA, Hodi Z, Ellis IO (2011) Breast carcinomas with borderline (2+) HER2 immunohistochemistry: the percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification. J Clin Pathol 64:490\u2013492. https:\/\/doi.org\/10.1136\/jcp.2011.089177","journal-title":"J Clin Pathol"},{"key":"3356_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/modpathol.2008.195","volume":"22","author":"F Chibon","year":"2009","unstructured":"Chibon F, de Mascarel I, Sierankowski G, Brouste V, Bonnefoi H, Debled M, Mauriac L, MacGrogan G (2009) Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO\/CAP and FDA recommendations. Mod Pathol 22:403\u2013409. https:\/\/doi.org\/10.1038\/modpathol.2008.195","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03356-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T08:10:30Z","timestamp":1659341430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03356-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3356"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03356-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"10 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}